NEW YORK (GenomeWeb) – Tempus and the University of Michigan's Comprehensive Cancer Center have announced a collaboration aimed at identifying the most effective care for breast cancer patients by analyzing molecular data related to in vitro biological models.

"While progress has been made in the battle against breast cancer, there are still too many unknowns that put the lives of those diagnosed at risk," Tempus Cofounder and CEO Eric Lefkofsky said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.